Answers are grounded in this paper and cite their sources.
LINC00460 may be a novel oncogene of CRC through interacting with IGF2BP2 and DHX9 and bind to the m6A modified HMGA1 mRNA to enhance the HMGA1 mRNA stability. LINC00460 can serve as a promising predictive biomarker for the diagnosis and prognosis among patients with CRC.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: